Kingsley Eze

Prevention of Respiratory Syncytial Virus Infection in Healthy Adults by a Single Immunization of Ad26.RSV.preF in a Human Challenge Study

Rob Lambkin-Williams, A. Gilbert, H. Schuitemaker, 2021, The Journal of infectious diseases.

Vaccine Efficacy in Adults in a Respiratory Syncytial Virus Challenge Study.

A. Mann, P. Dormitzer, A. Gurtman, 2022, The New England journal of medicine.

LB6. EDP-938, a Novel RSV N-Inhibitor, Administered Once or Twice Daily Was Safe and Demonstrated Robust Antiviral and Clinical Efficacy in a Healthy Volunteer Challenge Study

E. Coakley, Kai Lin, K. Larson, 2019, Open Forum Infectious Diseases.

The current epidemiological status of urogenital schistosomiasis among primary school pupils in Katsina State, Nigeria: An imperative for a scale up of water and sanitation initiative and mass administration of medicines with Praziquantel

T. Atalabi, Kingsley Eze, Stephen Dumebi Adoh, 2018, PLoS neglected tropical diseases.

Correction: Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model

Daniel J. Fullen, Rob Lambkin-Williams, A. Mann, 2016, PloS one.

Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model

Daniel J. Fullen, Rob Lambkin-Williams, A. Mann, 2016, PloS one.

EDP-938, a Respiratory Syncytial Virus Inhibitor, in a Human Virus Challenge.

N. Noulin, J. Mori, N. Adda, 2022, The New England journal of medicine.